ACM
RVMD icon

AH Capital Management’s Revolution Medicines RVMD Stock Holding History

AH Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.6M Hold
921,099
– – 6.94% 4
2025
Q4 		$73.4M Sell
921,099
-1,827,424
-66% -$120M 4.64% 4
2025
Q3 		$128M Hold
2,748,523
– – 9.2% 3
2025
Q2 		$101M Hold
2,748,523
– – 32.32% 1
2025
Q1 		$97.2M Hold
2,748,523
– – 13.87% 3
2024
Q4 		$120M Hold
2,748,523
– – 16.13% 3
2024
Q3 		$125M Hold
2,748,523
– – 10.96% 3
2024
Q2 		$107M Hold
2,748,523
– – 9.1% 5
2024
Q1 		$88.6M Sell
2,748,523
-2,948,544
-52% -$87.4M 6.41% 5
2023
Q4 		$163M Buy
+5,697,067
New +$137M 10.06% 4

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AH Capital Management's RVMD Position: Q1 2026 in Review

AH Capital Management held its Revolution Medicines (RVMD) position steady in Q1 2026 at 921,099 shares worth $89.6M. The position accounts for 6.94% of the portfolio, ranked #4.

AH Capital Management first reported a position in RVMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $163M in Q4 2023. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • AH Capital Management held 921,099 shares of Revolution Medicines worth $89.6M as of Q1 2026.
  • AH Capital Management left its Revolution Medicines share count unchanged in Q1 2026.
  • Revolution Medicines made up 6.94% of AH Capital Management's portfolio in Q1 2026, its #4 holding.
  • AH Capital Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 10 quarters since.
  • AH Capital Management's Revolution Medicines position peaked at $163M in Q4 2023.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on AH Capital Management's 13F filing for Q1 2026, filed 15 May 2026.